Image

Impact of Olfactory Odour StimulatioN on Energy EXpenditure

Impact of Olfactory Odour StimulatioN on Energy EXpenditure

Recruiting
18-55 years
All
Phase N/A

Powered by AI

Overview

In this preliminary short-term study it is investigated, whether a short olfactory stimulation with distinct odours impacts energy expenditure in patients with obesity and lean patients.

Eligibility

Inclusion Criteria:

  • • Age 18-55 years
    • Obesity (BMI ≥30 kg/m2) and Lean (BMI 18-25 kg/m2)
    • Written informed consent
    • Normosmia (defined by sniffing Sticks test)

Exclusion Criteria:

  • • Chronic or acute sinusitis
    • Surgical intervention of the nasal cavity or the paranasal sinus
    • Known allergy to odors used in the study
    • Smokers
    • Current illicit drug abuse including daily marijuana and cannabidiol (CBD) consumption (alcohol ≤2 drinks per day allowed)
    • Any kind of severe chronic disease (e.g. severe heart failure, active cancer disease)
    • Diabetes mellitus
    • Treatment with insulin sensitizing drugs including Glucagon-like Peptide (GLP)-1 analogues within the last 3 months
    • History of neurodegenerative diseases, severe head trauma
    • Severe renal impairment (e.g. estimated glomerular filtration rate <30 ml/min/m2)
    • Known liver cirrhosis or other severe liver impairment
    • Use of any kind of decongestant more than twice a week
    • Use of cortisone-containing nasal spray within the last 3 months
    • Acute upper respiratory tract infection
    • Uncontrolled dysthyroidism
    • Uncontrolled hypertension
    • Regular use of psychopharmaceutic drugs
    • Study participants aims to start a new diet or exercise program during the study
    • Bariatric surgery
    • Pregnancy/Lactation
    • Onset of climacteric symptoms within one year (e.g. hot flashes and/or diaphoresis) OR initiation of hormonal replacement therapy in the last three months
    • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc.
    • Participation in an interventional study within the last 3 months

Study details
    Obesity

NCT05472168

University Hospital, Basel, Switzerland

27 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.